Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study / Di Bartolomeo, M; Ciarlo, A; Bertolini, A; Barni, S; Verusio, C; Aitini, E; Pietrantonio, F; Iacovelli, Roberto; Dotti, Kf; Maggi, C; Perrone, F; Bajetta, E.. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - (2015). [10.1016/j.ejca.2014.12.020]
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study.
IACOVELLI, ROBERTO;
2015
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
